Cite

HARVARD Citation

    Perreault, S. et al. (2021). Comparative effectiveness and safety of high‐dose rivaroxaban and apixaban for atrial fibrillation: A propensity score‐matched cohort study. Pharmacotherapy. 41 (4), pp. 379-393. [Online]. 
  
Back to record